Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Long-Acting Injectable Antiretroviral Therapy


Date: Jun 23, 2020 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Aug 18, 2020 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Long-Acting Injectable Antiretroviral Therapy

 

 

 

Objectives

  • Define place in therapy for long-acting injectable antiretroviral therapy
  • Explain practical considerations for long-acting injectable antiretroviral therapy
  • Outline evidence regarding safety and efficacy of long-acting cabotegravir
  • Summarize important characteristics of ibalizumab
  • Explain practical considerations for long-acting injectable antiretroviral therapy

Speaker(s)/Author(s)

Sabeen Ali

Activity Number

0010-0000-20-021-L02-P
Date: 06/23/20
Time: 12:00 PM - 01:00 PM

CE Hours

1.00

Location

Clinical Pharmacy Associates Webinar